Drug Profile
Influenza virus vaccine Agrippal S1 - Seqirus
Alternative Names: Agrippal S1; Begripal; Chiroflu; Sandovac; Subunit-influenza-virus-vaccine; Trivalent subunit inactivated influenza virus vaccineLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Novartis; Novartis Vaccines
- Developer Novartis; Seqirus
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections